Icon

LUMISIGHT (NDA214511)- (EQ 40MG BASE/VIAL)

PEGULICIANINE ACETATE LUMICELL
EQ 40MG BASE/VIAL
No No
2034-Sep-14 2029-Apr-17
None None
None No
LUMISIGHT is an optical imaging agent indicated for fluorescence imaging in adults with breast cancer as an adjunct for the intraoperative detection of cancerous tissue within the resection cavity following removal of the primary specimen during lumpectomy surgery.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 40MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.